Filing Flows

Filing Flows › Angiodynamics (ANGO) › Recalls, complaints & regulation

Angiodynamics (ANGO): recalls and clinical trials

Angiodynamics (ANGO) beyond its filings: 20 recalls in the last 12 months (59 in five years, 0 Class I); 10 active clinical trials.

Latest recalls

Angiodynamics' latest quarter

Angiodynamics, Q1 FY27: revenue $80.9M (+7% year over year), operating margin -9.0%, net loss $7.1M, operating cash flow −$15.3M. The chart follows the revenue to costs, profit and cash.

Questions

Has Angiodynamics had any recalls?

59 recalls on file over five years from the FDA, CPSC and NHTSA; 20 in the last 12 months.

How many clinical trials does Angiodynamics have?

10 active studies on ClinicalTrials.gov, 1 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.